172 related articles for article (PubMed ID: 29784119)
41. Indications, technical aspects, and outcomes of stent placement in chronic iliofemoral venous obstruction.
Bai H; Kibrik P; Shaydakov ME; Singh M; Ting W
J Vasc Surg Venous Lymphat Disord; 2024 May; ():101904. PubMed ID: 38759753
[TBL] [Abstract][Full Text] [Related]
42. Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?
Ludyga T; Kazibudzki M; Simka M; Hartel M; Swierad M; Piegza J; Latacz P; Sedlak L; Tochowicz M
Phlebology; 2010 Dec; 25(6):286-95. PubMed ID: 21107001
[TBL] [Abstract][Full Text] [Related]
43. A novel design biodegradable stent for use in congenital heart disease: mid-term results in rabbit descending aorta.
Veeram Reddy SR; Welch TR; Wang J; Richardson JA; Forbess JM; Riegel M; Nugent AW
Catheter Cardiovasc Interv; 2015 Mar; 85(4):629-39. PubMed ID: 25157439
[TBL] [Abstract][Full Text] [Related]
44. Role of stent grafts for the treatment of failing hemodialysis accesses.
Peden EK
Semin Vasc Surg; 2011 Jun; 24(2):119-27. PubMed ID: 21889101
[TBL] [Abstract][Full Text] [Related]
45. So We Have Bioresorbable Scaffolds: Now What?
King SB
JACC Cardiovasc Interv; 2016 May; 9(10):1087-8. PubMed ID: 27198690
[No Abstract] [Full Text] [Related]
46. Stenting of stenotic or occluded iliofemoral veins, superior and inferior vena cavae in children with congenital heart disease: acute results and intermediate follow up.
Frazer JR; Ing FF
Catheter Cardiovasc Interv; 2009 Feb; 73(2):181-8. PubMed ID: 19156885
[TBL] [Abstract][Full Text] [Related]
47. Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease.
Rossi FH; Kambara AM; Izukawa NM; Rodrigues TO; Rossi CB; Sousa AG; Metzger PB; Thorpe PE
J Vasc Surg Venous Lymphat Disord; 2018 Mar; 6(2):183-191. PubMed ID: 29292114
[TBL] [Abstract][Full Text] [Related]
48. Central Venous Pathologies: Treatments and Economic Impact.
Ouriel K
Methodist Debakey Cardiovasc J; 2018; 14(3):166-172. PubMed ID: 30410645
[TBL] [Abstract][Full Text] [Related]
49. The Bolton Treovance abdominal stent-graft: European clinical trial design.
Chiesa R; Riambau V; Coppi G; Zipfel B; Llagostera S; Marone EM; Kahlberg A;
J Cardiovasc Surg (Torino); 2012 Oct; 53(5):595-604. PubMed ID: 22955554
[TBL] [Abstract][Full Text] [Related]
50. Stent placement for treatment of central and peripheral venous obstruction: a long-term multi-institutional experience.
Oderich GS; Treiman GS; Schneider P; Bhirangi K
J Vasc Surg; 2000 Oct; 32(4):760-9. PubMed ID: 11013040
[TBL] [Abstract][Full Text] [Related]
51. Midterm results from a physician-sponsored investigational device exemption clinical trial evaluating physician-modified endovascular grafts for the treatment of juxtarenal aortic aneurysms.
Starnes BW; Heneghan RE; Tatum B
J Vasc Surg; 2017 Feb; 65(2):294-302. PubMed ID: 27687323
[TBL] [Abstract][Full Text] [Related]
52. Venous Stent Placement for Refractory Ascites due to Hepatic Venous Outflow Obstruction in Polycystic Liver Disease.
Bernts LHP; Tjwa ETTL; D'Agnolo HMA; Jenniskens SFM; Drenth JPH
J Vasc Interv Radiol; 2019 Oct; 30(10):1617-1619. PubMed ID: 31005489
[No Abstract] [Full Text] [Related]
53. Chronic cerebrospinal venous insufficiency and multiple sclerosis.
Khan O; Filippi M; Freedman MS; Barkhof F; Dore-Duffy P; Lassmann H; Trapp B; Bar-Or A; Zak I; Siegel MJ; Lisak R
Ann Neurol; 2010 Mar; 67(3):286-90. PubMed ID: 20373339
[TBL] [Abstract][Full Text] [Related]
54. Chronic iliac vein occlusion: midterm results of endovascular recanalization.
Kölbel T; Lindh M; Akesson M; Wassèlius J; Gottsäter A; Ivancev K
J Endovasc Ther; 2009 Aug; 16(4):483-91. PubMed ID: 19702343
[TBL] [Abstract][Full Text] [Related]
55. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
56. Iliac vein stenting for chronic venous insufficiency.
Mussa FF; Peden EK; Zhou W; Lin PH; Lumsden AB; Bush RL
Tex Heart Inst J; 2007; 34(1):60-6. PubMed ID: 17420795
[TBL] [Abstract][Full Text] [Related]
57. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
58. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease.
Sarode K; Spelber DA; Bhatt DL; Mohammad A; Prasad A; Brilakis ES; Banerjee S
JACC Cardiovasc Interv; 2014 Aug; 7(8):827-39. PubMed ID: 25147028
[TBL] [Abstract][Full Text] [Related]
59. Push-Up Technique and Anatomical Deployment With the Endurant Stent-Graft System for Severely Angulated Aneurysm Necks.
Dohi S; Yokoyama Y; Yamamoto T; Kuwaki K; Hariya A; Kajimoto K; Yamaoka H; Shimada A; Tsuruta R; Amano A
J Endovasc Ther; 2017 Jun; 24(3):435-439. PubMed ID: 28205450
[TBL] [Abstract][Full Text] [Related]
60. Long term follow-up of endo-vascular recanalization of chronic inferior vena cava occlusion secondary to inferior vena cava filters.
Partovi S; Kalva SP; Walker TG; Taj SM; Ganguli S
Vasa; 2017 Mar; 46(2):121-126. PubMed ID: 28247824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
